文献速递针灸推拿中医内科

针刺联合羟氯喹治疗原发性干燥综合征的疗效与安全性:随机对照试验

Efficacy and Safety of Acupuncture Combined with Hydroxychloroquine in Treating Primary Sjögren's Syndrome: A Randomized Controlled Trial.
PubMed 文献 · Chin J Integr Med · 2026-10-02

本研究为随机对照试验,纳入138例原发性干燥综合征患者,均分至针刺联合羟氯喹组或假针刺联合羟氯喹组。结果显示,联合针刺组在改善口干、眼干症状及ESSDAI评分方面优于对照组,且安全性良好,并可能通过改善临床症状间接缓解焦虑抑郁。

要点

  • 针刺联合羟氯喹可更有效改善pSS患者口干、眼干症状及ESSDAI评分。
  • 联合治疗组HADS-A评分显著低于对照组,焦虑改善明显。
  • 两组不良事件发生率无显著差异,安全性良好。

核心结论

  • 针刺联合羟氯喹治疗pSS在改善口干、眼干症状方面优于单用羟氯喹,且安全性良好。
  • 针刺可能通过改善口干眼干等临床结局间接缓解焦虑和抑郁症状。

研究设计与样本

  • 随机对照试验,纳入138例pSS患者,均分至治疗组(针刺+羟氯喹)和对照组(假针刺+羟氯喹),每组69例。
  • 治疗组接受针刺穴位包括百会、足三里、三阴交、太溪等,两组均治疗8个疗程,随访4周。

主要发现

  • 治疗后两组ESSPRI、眼干NRS、口干NRS、ESSDAI评分均较基线下降,唾液流率、Schirmer试验、泪膜破裂时间均较基线升高(P<0.05)。
  • 治疗组ESSPRI、眼干NRS、口干NRS显著低于对照组,唾液流率、Schirmer试验、BUT显著高于对照组(均P<0.05)。
  • 治疗组HADS-A评分显著低于对照组(P<0.001);HADS-D评分FAS分析组间差异P=0.020,PPS分析P=0.003,治疗组内改善P=0.012。
  • 两组不良事件发生率无显著差异(P>0.05)。

关键数值与推荐

  • 主要疗效终点为ESSPRI评分。
  • 针刺穴位包括百会(GV20)、足三里(ST36)、三阴交(SP6)、太溪(KI3)等。
  • 羟氯喹用法为硫酸羟氯喹片0.2g,每日两次。

临床怎么用

  • 对于pSS患者,可考虑在羟氯喹基础上联合针刺治疗以改善口干、眼干症状。
  • 针刺可能有助于缓解pSS患者的焦虑和抑郁情绪,可作为辅助治疗选择。

局限性

  • 完成全疗程治疗的患者为治疗组57例、对照组62例,存在脱落。
  • 原文未报告盲法实施细节、样本量计算依据等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the efficacy and safety of acupuncture combined with hydroxychloroquine (HCQ) in patients with primary Sjögren's syndrome (pSS) and to explore the underlying mechanisms of acupuncture effect. METHODS: This study was designed as a randomized controlled trial (RCT) and included 138 pSS patients who were equally and randomly assigned to the treatment group or the sham acupuncture control group (69 cases in each group). The control group received HCQ sulfate tablets (0.2 g, twice daily) combined with sham acupuncture, whereas the treatment group received real acupuncture in addition to HCQ treatment. Acupuncture at Baihui (GV 20), Zusanli (ST 36), Sanyinjiao (SP 6), Taixi (KI 3), etc. was administered. Both groups underwent 8 treatment courses, with a 4-week follow-up. The primary efficacy endpoint was the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) score. The secondary endpoints included clinical symptom scores, laboratory indicators, and scores for anxiety (Hospital Anxiety and Depression Scale-anxiety, HADS-A) and depression (HADS-D). Safety assessments including vital signs monitoring and laboratory tests were conducted at weeks 0, 2, 4, 6, and 8, and adverse events were evaluated throughout the study. RESULTS: A total of 57 patients in the treatment group and 62 in the control group completed the full course of treatment. After treatment, both groups presented a reduction in ESSPRI scores, eye dryness numerical rating scale (NRS), mouth dryness NRS, and EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) scores compared with the baseline values and an increase in the salivary flow rate, Schirmer test results, and tear film break-up time (BUT) scores compared with the baseline values (P<0.05). The erythrocyte sedimentation rate (ESR), IgG, and IgA level were significantly lower than those at baseline (all P<0.05). Compared with the control group, the treatment group had significantly lower ESSPRI scores, eye dryness NRS, and mouth dryness NRS and significantly higher salivary flow rates, Schirmer test results, and BUT scores (all P<0.05), as well as lower HADS-A scores (P<0.001); both groups had a statistically significant difference in FAS analysis of HADS-D scores (P=0.020), and the difference was more significant in PPS analysis (P=0.003), with significant improvement within the treatment group (P=0.012). The incidence of adverse events was not significantly different between the two groups (P>0.05). CONCLUSIONS: Acupuncture combined with HCQ treatment is more effective than HCQ alone in improving dry mouth and dry eye symptoms in pSS patients, with a good safety profile. Additionally, acupuncture treatment may indirectly alleviate anxiety and depression symptoms by improving clinical outcomes such as dry mouth and dry eye. (Registration No. TCTR20230116003).

来源:Chin J Integr Med,查看原文。版权归原作者所有。

引用

  1. Li JB, Lu H, Fan YH, et al. Efficacy and Safety of Acupuncture Combined with Hydroxychloroquine in Treating Primary Sjögren's Syndrome: A Randomized Controlled Trial. Chin J Integr Med. 2026. PMID: 42826003. doi:10.1007/s11655-026-4253-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。